Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetic study of intravenous esketamine in children
ChiCTR2200066077Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine (5 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Blood concentration of esketamine at 24 hours, Blood concentration of S-norketamine at 24 hours and 2 more. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2200066077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066077.